Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/14/2014CN102727884B 猪繁殖与呼吸综合征、伪狂犬病二联活疫苗及其制备方法 Porcine reproductive and respiratory syndrome, pseudo-rabies vaccine combined living and preparation method
05/14/2014CN102727883B 猪繁殖与呼吸综合征与猪瘟二联疫苗及其用途 Porcine reproductive and respiratory syndrome and swine fever bivalent vaccine and its use
05/14/2014CN102727882B 猪繁殖与呼吸综合征、猪瘟、伪狂犬病的三联活疫苗及其制备方法 Triple live vaccine and its preparation method of porcine reproductive and respiratory syndrome, swine fever, pseudorabies
05/14/2014CN102727524B 一种抗cd3/抗cd133双特异性抗体装载的cik细胞的应用 A cd3 / anti-cd133 bispecific antibody cells loaded with anti-cik
05/14/2014CN102648979B 肺炎链球菌3型多糖的纯化 Purification of pneumococcal polysaccharide type 3
05/14/2014CN102586166B 表达禽脑脊髓炎病毒vp1蛋白重组菌的构建 Construction of expression of recombinant proteins of avian encephalomyelitis virus strains vp1
05/14/2014CN102533674B 表达禽流感病毒血凝素基因的重组鸭病毒性肠炎病毒疫苗株及其构建方法和应用 Expression of recombinant duck avian influenza virus hemagglutinin gene of viral enteritis virus vaccine strain and its construction method and application
05/14/2014CN102333543B 细胞粘附抑制剂及其用途 Cell adhesion inhibitors and their use
05/14/2014CN102302773B 冷藏温度稳定的流感疫苗组合物 Refrigeration temperature stabilized influenza vaccine composition
05/14/2014CN102264373B 用于原位肿瘤破坏疗法的免疫刺激性皂苷类 For in situ tumor destruction immunostimulatory therapy saponins
05/14/2014CN102250245B 抗b细胞淋巴瘤的双特异性抗体及其用途 Anti-b-cell lymphoma bispecific antibodies and uses thereof
05/14/2014CN102241774B 重组IgE-Fc-抗EGFR单链抗体融合蛋白及其制备方法和用途 IgE-Fc- anti-EGFR recombinant single-chain antibody fusion proteins and their preparation and use
05/14/2014CN102241773B 抗骨髓瘤细胞多克隆抗体及其制备方法 Polyclonal anti-myeloma cells and its preparation method
05/14/2014CN102209558B 使用促性腺激素释放激素(gnrh)组合的变体作为免疫原的药物组合物 Use of gonadotropin-releasing hormone (gnrh) combination variants as immunogens pharmaceutical composition
05/14/2014CN102167745B 一种全人源抗IgE单克隆抗体、其制备方法及用途 One kind of fully human monoclonal anti-IgE antibodies, their preparation and use
05/14/2014CN102167743B 一种全人源抗egfr单克隆抗体、其制备方法及用途 One kind of fully human anti-egfr monoclonal antibodies, their preparation and use
05/14/2014CN102167742B 一种全人源抗her2单克隆抗体、其制备方法及用途 One kind of fully human monoclonal antibody anti-her2, their preparation and use
05/14/2014CN102167741B 一种全人源抗TNF-α单克隆抗体、其制备方法及用途 One kind of fully human anti-TNF-α monoclonal antibodies, their preparation and use
05/14/2014CN102131524B 成纤维细胞生长因子受体2的单克隆抗体 Fibroblast growth factor receptor 2 Monoclonal Antibody
05/14/2014CN102112489B 抗-hepcidin-25选择性抗体及其用途 Anti -hepcidin-25 selective antibody and its use
05/14/2014CN101970485B 肝素结合表皮生长因子样生长因子抗原结合蛋白 Heparin-binding epidermal growth factor-like growth factor binding protein antigen
05/14/2014CN101939425B 抗il-6受体抗体 Anti-il-6 receptor antibody
05/14/2014CN101939336B Axl抗体 Axl antibody
05/14/2014CN101878036B 包含促胰岛素释放肽缀合物的治疗肥胖相关疾病的药物组合物 To promote the treatment of obesity-related diseases comprising a pharmaceutical composition for the release of insulin peptide conjugate
05/14/2014CN101687031B 用于治疗眼疾和眼病的组合物及方法 Treatment of eye diseases and eye diseases, compositions and methods for
05/14/2014CN101573137B 适用于治疗犬的犬病的疫苗 For the treatment of canine vaccines Quanbing
05/14/2014CN101516393B 热处理菌苗和由该热处理菌苗制备的乳液疫苗 Heat treatment vaccine and vaccine prepared from the heat emulsion vaccine
05/14/2014CN101052413B 特异性组蛋白在治疗寄生虫病中的应用 Application-specific histone in the treatment of parasitic diseases
05/13/2014US8722871 VMP-like sequences of pathogenic borrelia species and strains
05/13/2014US8722869 Class of therapeutic protein based molecules
05/13/2014US8722861 Monoclonal antibodies that bind to the V3 loop of HIV-1 gp120
05/13/2014US8722860 Anti-TNF-α antibodies and their uses
05/13/2014US8722859 Multivalent antibodies and uses therefor
05/13/2014US8722622 FGF21 conjugates and anti-diabetic uses thereof
05/13/2014US8722613 Methods and compositions for inhibition of nuclear factor kappaB
05/13/2014US8722400 Artificial antigen presenting cells and uses therefor
05/13/2014US8722341 Metapneumovirus strains and their use in vaccine formulations and sequences
05/13/2014US8722324 Methods for the detection of HIV-1-specific antibodies employing GP41 polypeptides
05/13/2014US8722064 Synthetic glucopyranosyl lipid adjuvants
05/13/2014US8722063 Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
05/13/2014US8722062 Multivalent meningococcal polysaccharide-protein conjugate vaccine
05/13/2014US8722061 Antibody profiles characteristic of tuberculosis state
05/13/2014US8722060 Method of treating vertigo
05/13/2014US8722059 Multi plasmid system for the production of influenza virus
05/13/2014US8722058 Bacillus strains and methods for reducing E. coli disease and enhancing performance
05/13/2014US8722057 Method for producing β-carotene rich Dunaliella powder
05/13/2014US8722055 Synthetic Streptococcus pneumoniae vaccine
05/13/2014US8722053 IgE CH3 peptide vaccine
05/13/2014US8722052 Vaccinia virus protein A46 peptide and use thereof
05/13/2014US8722051 Tweak receptor
05/13/2014US8722050 Method of treating virus-induced cancer
05/13/2014US8722049 Antibody and methods for selective inhibition of T-cell responses
05/13/2014US8722048 T-cell receptor capable of recognising an antigen from cytomegalovirus
05/13/2014US8722047 Humanized anti-HLA-DR antibodies
05/13/2014US8722046 Human monoclonal antibodies protective against bubonic plague
05/13/2014US8722045 Cell and therapeutical and diagnostical methods based thereon
05/13/2014US8722044 Human tissue factor antibody and uses thereof
05/13/2014US8722043 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
05/13/2014US8722042 Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease
05/13/2014US8722036 Methods for treating malignancies using coxsackieviruses
05/13/2014US8722033 Human IL-23 antigen binding proteins
05/13/2014CA2715324C Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
05/13/2014CA2648086C Methods and compositions for inducing an immune response to hiv and models for testing
05/13/2014CA2627457C Botulinum neurotoxin a protein receptor and uses thereof
05/13/2014CA2546054C Interferon alpha antibodies and their uses
05/13/2014CA2514058C Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
05/13/2014CA2441947C Human papilloma virus immunoreactive peptides
05/13/2014CA2386014C Influenza vaccine
05/13/2014CA2270345C Immunostimulatory nucleic acid molecules
05/08/2014WO2014071402A1 Xbp1, cd138, and cs1, pharmaceutical compositions that include the peptides, and methods of using such petides and compositions
05/08/2014WO2014071211A2 Molecules, compositions and methods to treat organ scarring
05/08/2014WO2014071206A1 Anti-complement c1s antibodies and uses thereof
05/08/2014WO2014071128A1 Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques
05/08/2014WO2014071125A1 Combination of anti-cd20 antibody and pi3 kinase selective inhibitor
05/08/2014WO2014071074A2 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
05/08/2014WO2014070957A1 Antibody/drug conjugates and methods of use
05/08/2014WO2014070953A1 Methods of Using FVIII Polypeptide
05/08/2014WO2014070934A1 Anti-cd40 antibodies and methods of use
05/08/2014WO2014070865A1 Sortase-catalyzed immobilization, release, and replacement of functional molecules on solid surfaces
05/08/2014WO2014070848A1 Universal influenza vaccine based on heterologous multiple m2e proteins
05/08/2014WO2014070840A2 Stimulating bone formation by inhibition of cd28 co-stimulation
05/08/2014WO2014070786A1 Compositions and methods for inhibiting pathogen infection
05/08/2014WO2014070696A2 Medicinal treatment of chronic dermal inflammatory diseases with norketotifen
05/08/2014WO2014070663A1 Compositions and methods for diagnosis and treatment of malignant gliomas
05/08/2014WO2014070659A1 Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
05/08/2014WO2014070117A1 Monoclonal antibody against muramyl peptides
05/08/2014WO2014070109A1 An enterovirus 71 specific antibody
05/08/2014WO2014069789A1 Agent for treating asthma
05/08/2014WO2014069757A1 Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase
05/08/2014WO2014069682A1 Cancer-targeting antibody and composition for preventing or treating cancer comprising same
05/08/2014WO2014069681A1 Cancer-targeting antibody and composition for preventing or treating cancer comprising same
05/08/2014WO2014069655A1 Immune-tolerance inducer
05/08/2014WO2014068132A1 Binding members to il-1 beta
05/08/2014WO2014068079A1 An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
05/08/2014WO2014068029A1 Lyophilized formulation comprising gm-csf neutralizing compound
05/08/2014WO2014068026A1 Liquid formulation comprising gm-csf neutralizing compound
05/08/2014WO2014068021A1 Method for preparation of a high concentration liquid formulation of an antibody
05/08/2014WO2014068001A1 Recombinant particle based vaccines against human cytomegalovirus infection
05/08/2014WO2014067993A1 New fusion proteins for the treatment of allergic diseases
05/08/2014WO2014067912A1 Staphylococcus aureus sdre cnab domain and its use for vaccination
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 1823